Publications by authors named "Jong-Mu Sun"

215 Publications

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.

Eur J Immunol 2021 Jan 28. Epub 2021 Jan 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

View Article and Find Full Text PDF
January 2021

Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs.

Immune Netw 2020 Dec 21;20(6):e48. Epub 2020 Dec 21.

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.

View Article and Find Full Text PDF
December 2020

The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer.

Transl Lung Cancer Res 2020 Oct;9(5):1749-1758

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
October 2020

Regulatory (FoxP3) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer.

Sci Rep 2020 11 4;10(1):18994. Epub 2020 Nov 4.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, 81 Irwon-ro, Gangnam-gu, Seoul, Republic of Korea.

View Article and Find Full Text PDF
November 2020

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.

Cancer Immunol Immunother 2020 Oct 29. Epub 2020 Oct 29.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article and Find Full Text PDF
October 2020

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon Mutations: Are They Different from Those with Common Mutations?

Biology (Basel) 2020 Oct 7;9(10). Epub 2020 Oct 7.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article and Find Full Text PDF
October 2020

Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation.

Eur J Cardiothorac Surg 2020 Nov;58(5):1019-1026

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
November 2020

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?

J Thorac Dis 2020 Jul;12(7):3796-3803

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article and Find Full Text PDF
July 2020

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma.

Authors:
Jong-Mu Sun

Korean J Thorac Cardiovasc Surg 2020 Aug;53(4):168-171

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
August 2020

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.

BMC Cancer 2020 Aug 5;20(1):727. Epub 2020 Aug 5.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article and Find Full Text PDF
August 2020

Evaluating entrectinib as a treatment option for non-small cell lung cancer.

Expert Opin Pharmacother 2020 Nov 31;21(16):1935-1942. Epub 2020 Jul 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Korea.

View Article and Find Full Text PDF
November 2020

Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.

Expert Opin Investig Drugs 2020 Sep 29;29(9):1059-1067. Epub 2020 Aug 29.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.

View Article and Find Full Text PDF
September 2020

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.

Cancer Res Treat 2020 Oct 22;52(4):1288-1290. Epub 2020 Jun 22.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
October 2020

Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.

Cancer 2020 Sep 25;126(17):4002-4012. Epub 2020 Jun 25.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article and Find Full Text PDF
September 2020

Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).

Lung Cancer 2020 08 31;146:112-119. Epub 2020 May 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

View Article and Find Full Text PDF
August 2020

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer.

Lung Cancer 2020 08 31;146:23-29. Epub 2020 May 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article and Find Full Text PDF
August 2020

Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma.

Eur J Cancer 2020 06 1;132:150-158. Epub 2020 May 1.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article and Find Full Text PDF
June 2020

Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With Exon 14 Skipping.

In Vivo 2020 May-Jun;34(3):1399-1406

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

View Article and Find Full Text PDF
February 2021

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Cancers (Basel) 2020 Apr 10;12(4). Epub 2020 Apr 10.

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article and Find Full Text PDF
April 2020

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer.

Korean J Intern Med 2020 Apr 3. Epub 2020 Apr 3.

Division of Hematology-Oncology, Department of Medicine, , Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
April 2020

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors.

Sci Rep 2020 03 19;10(1):5077. Epub 2020 Mar 19.

Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (SKKU-SOM), Seoul, South Korea.

View Article and Find Full Text PDF
March 2020

Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.

Cancer 2020 06 10;126(11):2704-2712. Epub 2020 Mar 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
June 2020

Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.

Jpn J Clin Oncol 2020 May;50(5):594-601

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
May 2020